-
公开(公告)号:EP3226864A1
公开(公告)日:2017-10-11
申请号:EP15864946.7
申请日:2015-12-02
申请人: Pharmacyclics LLC
IPC分类号: A61K31/445 , C07D487/04 , C09B31/147
CPC分类号: A61K31/519 , A61K31/7068 , C09B31/147 , A61K2300/00
摘要: Disclosed are methods of treating fibrosis in a patient, comprising administering to a patient in need thereof a therapeutically effective amount of an ACK inhibitor (e.g., a BTK inhibitor, such as for example an irreversible BTK inhibitor, such as for example, ibrutinib).
摘要翻译: 公开了治疗患者纤维化的方法,其包括向有需要的患者施用治疗有效量的ACK抑制剂(例如,BTK抑制剂,例如不可逆的BTK抑制剂,例如依鲁替尼)。